Aelis Farma (XPAR:AELIS) FFO


XPAR:AELIS Aelis Farma SA XPAR:AELIS
32 GF Score
Price €1.07
GF Value €0.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:AELIS
32GF Score
Aelis Farma SA XPAR:AELIS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aelis Farma (XPAR:AELIS) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.07 is trading 9.2% above its estimated GF Value™ of €0.98. GuruFocus considers Aelis Farma to be Fairly Valued.

Key valuation signals for XPAR:AELIS:

  • FFO:
  • GF Value™: €0.98 vs. price of €1.07 (9.2% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the XPAR:AELIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aelis Farma Business Description

Other Exchanges 69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for XPAR:AELIS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.07
Price
€0.98
GF Value